Australian Clinical Labs Ltd Net Asset Quality Index
Australian Clinical Labs Ltd net asset quality index. Australian Clinical Labs Ltd (ACL) has a Net Asset Quality Index of 26.9% as of December 2025. This metric measures the proportion of total assets financed by shareholders' equity — total assets of AU$562.50 Million minus total liabilities of AU$411.46 Million yields net assets of AU$151.04 Million. A higher index indicates a stronger, lower-leverage balance sheet. See net assets of Australian Clinical Labs Ltd for net asset value and shareholders' equity analysis.
Quality Index
Net Assets
Total Assets
Total Liabilities
Net Asset Quality Index of Australian Clinical Labs Ltd (2016–2025)
Net asset quality index of Australian Clinical Labs Ltd from 2016 to 2025. This chart shows how Australian Clinical Labs Ltd's Net Asset Quality Index has evolved across 18 annual periods from 2016 to 2025. As of December 2025, the index stands at 26.9%, representing net assets of AU$151.04 Million against total assets of AU$562.50 Million AUD. Check strategic asset allocation of Australian Clinical Labs Ltd to assess the company's strategic physical and investment asset allocation.
Australian Clinical Labs Ltd Net Asset Quality Index by Year (2016–2025)
Australian Clinical Labs Ltd net asset quality index by year from 2016 to 2025. The table below presents the year-by-year Net Asset Quality Index for Australian Clinical Labs Ltd from 2016 to 2025, covering 18 annual filings. Each row shows total assets, total liabilities, net assets, the quality index percentage, and the change in percentage points compared to the prior year. For live market cap and overall valuation, see Australian Clinical Labs Ltd (ACL) market capitalisation.
| Year | Quality Index | Net Assets (AUD) | Total Assets | Total Liabilities | Change (pp) |
|---|---|---|---|---|---|
| 2025 | 29.9% | AU$171.98 Million | AU$574.84 Million | AU$402.86 Million | ▲ +0.0 pp |
| 2024 | 29.9% | AU$171.98 Million | AU$574.84 Million | AU$402.86 Million | ▼ -0.1 pp |
| 2024 | 30.0% | AU$177.76 Million | AU$593.06 Million | AU$415.30 Million | ▲ +0.0 pp |
| 2023 | 30.0% | AU$177.76 Million | AU$593.06 Million | AU$415.30 Million | ▲ +0.1 pp |
| 2023 | 29.8% | AU$172.67 Million | AU$578.91 Million | AU$406.24 Million | ▲ +0.0 pp |
| 2022 | 29.8% | AU$172.67 Million | AU$578.91 Million | AU$406.24 Million | ▼ -7.2 pp |
| 2022 | 37.0% | AU$232.56 Million | AU$628.04 Million | AU$395.49 Million | ▲ +0.0 pp |
| 2021 | 37.0% | AU$232.56 Million | AU$628.04 Million | AU$395.49 Million | ▲ +19.8 pp |
| 2021 | 17.3% | AU$81.91 Million | AU$474.70 Million | AU$392.79 Million | ▲ +0.0 pp |
| 2020 | 17.3% | AU$81.91 Million | AU$474.70 Million | AU$392.79 Million | ▼ -1.6 pp |
| 2020 | 18.8% | AU$68.99 Million | AU$366.05 Million | AU$297.06 Million | ▲ +0.0 pp |
| 2019 | 18.8% | AU$68.99 Million | AU$366.05 Million | AU$297.06 Million | ▲ +1.0 pp |
| 2019 | 17.9% | AU$27.42 Million | AU$153.61 Million | AU$126.19 Million | ▲ +0.0 pp |
| 2018 | 17.9% | AU$27.42 Million | AU$153.61 Million | AU$126.19 Million | ▲ +13.3 pp |
| 2018 | 4.6% | AU$5.46 Million | AU$119.06 Million | AU$113.60 Million | ▲ +0.0 pp |
| 2017 | 4.6% | AU$5.46 Million | AU$119.06 Million | AU$113.60 Million | ▼ -7.1 pp |
| 2017 | 11.7% | AU$14.12 Million | AU$120.89 Million | AU$106.77 Million | ▲ +0.0 pp |
| 2016 | 11.7% | AU$14.12 Million | AU$120.89 Million | AU$106.77 Million | — |